Tirzepatide at a Glance
Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has garnered significant attention in metabolic research. This 39-amino acid peptide exhibits unique dual mechanism properties through simultaneous activation of both incretin receptor pathways. Researchers investigating Stroid UK Shop analyse tirzepatide’s distinctive pharmacological profile in cellular studies and biochemical assays. The compound’s molecular structure incorporates fatty acid modifications that enhance stability and extend half-life in experimental systems, making it valuable for sustained research protocols.
Laboratory Applications
Scientific laboratories utilise tirzepatide 5mg formulations to examine incretin biology, glucose homeostasis mechanisms, and metabolic signalling pathways. Research applications include investigating receptor binding kinetics, signal transduction cascades, and comparative studies with other metabolic research compounds. The dual agonist activity provides unique research opportunities for studying synergistic incretin effects. Investigators analyse concentration-response relationships, receptor selectivity profiles, and downstream molecular effects in controlled laboratory environments. Studies often focus on understanding the compound’s interaction with GIP and GLP-1 receptor subtypes, examining binding affinity differences and functional selectivity patterns. Research teams evaluate metabolic pathways alongside complementary peptide compounds to comprehensively map incretin system interactions.
Technical Specifications
| Molecular Weight | Verify with supplier |
|---|---|
| CAS Number | Verify with supplier |
| Purity | Research grade |
| Form | Lyophilised powder |
| Storage | -20°C recommended |
| Stability | Extended when properly stored |
Compliance Statement
This tirzepatide preparation is manufactured exclusively for laboratory research applications. The compound is not approved for human consumption, clinical trials, or therapeutic use. Researchers must maintain proper laboratory protocols, ensure appropriate containment measures, and comply with institutional guidelines when conducting studies. All investigations should be performed within controlled laboratory environments by qualified research personnel familiar with peptide handling procedures and safety requirements.
